Portland Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-324
| Closed | -$341K | – | 57 |
|
|
2024
Q3 | $341K | Hold |
324
| – | – | 0.12% | 42 |
|
|
2024
Q2 | $341K | Sell |
324
-3
| -0.9% | -$3.15K | 0.12% | 43 |
|
|
2024
Q1 | $315 | Hold |
327
| – | – | 0.09% | 40 |
|
|
2023
Q4 | $287K | Hold |
327
| – | – | 0.1% | 33 |
|
|
2023
Q3 | $269K | Sell |
327
-3
| -0.9% | -$2.47K | 0.12% | 32 |
|
|
2023
Q2 | $237K | Hold |
330
| – | – | 0.12% | 35 |
|
|
2023
Q1 | $271K | Hold |
330
| – | – | 0.12% | 32 |
|
|
2022
Q4 | $238K | Hold |
330
| – | – | 0.14% | 32 |
|
|
2022
Q3 | $227K | Buy |
+330
| New | +$227K | 0.15% | 32 |
|
|
2022
Q2 | – | Sell |
-330
| Closed | -$230K | – | 37 |
|
|
2022
Q1 | $230K | Buy |
330
+1
| +0.3% | +$697 | 0.12% | 33 |
|
|
2021
Q4 | $208K | Buy |
+329
| New | +$208K | 0.09% | 36 |
|